We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-9.72%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.67B
AUM Growth
-$658M
Cap. Flow
+$79.2M
Cap. Flow %
1.19%
Top 10 Hldgs %
57.1%
Holding
295
New
64
Increased
76
Reduced
63
Closed
70

Top Buys

Rank Stock Value
1
FRPT icon
Freshpet
FRPT
+$87.7M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$59.2M
3
STAA icon
STAAR Surgical
STAA
+$42.7M
4
KDP icon
Keurig Dr Pepper
KDP
+$35.7M
5
SNN icon
Smith & Nephew
SNN
+$34.1M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$81.1M
2
NARI
Inari Medical, Inc. Common Stock
NARI
+$79.9M
3
GSK icon
GSK
GSK
+$73.2M
4
HUM icon
Humana
HUM
+$69.2M
5
BUD icon
AB InBev
BUD
+$68M

Sector Composition

Rank Sector Weight
1 Healthcare 35.45%
2 Consumer Discretionary 6.85%
3 Consumer Staples 5.47%
4 Technology 5.39%
5 Communication Services 1.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACONW icon
226
Aclarion Warrant
ACONW
$49.4K
– –
-34,375
Closed -$688
AIMDW icon
227
Ainos Warrants
AIMDW
$80.7K
– –
-5,000
Closed -$249
AISP
228
Airship AI Holdings
AISP
$71.3M
– –
-178,822
Closed -$1.12M
ALUR
229
DELISTED
Allurion Technologies
ALUR
– –
-301,096
Closed -$3.24M
APLE icon
230
Apple Hospitality REIT
APLE
$3.82B
– –
-274,407
Closed -$4.21M
AREBW
231
DELISTED
American Rebel Holdings Warrants
AREBW
– –
-21
Closed -$27
ARQQ icon
232
Arqit Quantum
ARQQ
$399M
– –
-47,000
Closed -$1.83M
BABA icon
233
Alibaba
BABA
$308B
– –
-124,000
Closed -$10.5M
BLMN icon
234
Bloomin' Brands
BLMN
$938M
– –
-250,000
Closed -$3.05M
BLTE
235
Belite Bio
BLTE
$6.54B
– –
-167,930
Closed -$10.6M
BTAI icon
236
BioXcel Therapeutics
BTAI
$27.8M
– –
-269,688
Closed -$1.61M
BUD icon
237
AB InBev
BUD
$165B
– –
-1,359,000
Closed -$68M
CINGW icon
238
Cingulate Inc Warrants
CINGW
$33.2K
– –
-1,708
Closed -$88
CKPT
239
DELISTED
Checkpoint Therapeutics
CKPT
– –
-4,460,545
Closed -$14.3M
CRSP icon
240
CRISPR Therapeutics
CRSP
$5.17B
– –
-208,000
Closed -$8.19M
CTM icon
241
Castellum
CTM
$58.3M
– –
-1,535,505
Closed -$3.07M
DNUT icon
242
Krispy Kreme
DNUT
$577M
– –
-325,000
Closed -$3.23M
DPRO
243
Draganfly
DPRO
$172M
– –
-480,794
Closed -$1.93M
DRMAW icon
244
Dermata Therapeutics Warrant
DRMAW
$12.4K
– –
-1,354
Closed -$14
EDBL
245
Edible Garden
EDBL
$1.2M
– –
-83
Closed -$299K
EDBLW
246
Edible Garden AG Warrant
EDBLW
$65.4K
– –
-1,334
Closed -$47
ELF icon
247
e.l.f. Beauty
ELF
$5.81B
– –
-154,419
Closed -$19.4M
EVAX
248
Evaxion A/S
EVAX
$25.9M
– –
-30,092
Closed -$127K
FEAM icon
249
5E Advanced Materials
FEAM
$62.3M
– –
-174,208
Closed -$2.56M
FL
250
DELISTED
Foot Locker
FL
– –
-485,000
Closed -$10.6M
8 9
10
11 12

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q1 2025 Portfolio in Review

As of Q1 2025, Armistice Capital held 295 positions worth $6.67B, down 9% from $7.33B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Armistice Capital's Q1 2025 filing shows 64 new, 76 increased, 63 reduced and 70 closed positions. Its largest new stake was Freshpet: 716,960 shares worth $59.6M. The largest sale was Vertex Pharmaceuticals, an estimated $81.1M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 39% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

  • Armistice Capital's largest Q1 2025 buy was Freshpet: 716,960 shares worth $59.6M.
  • Armistice Capital added most to Regeneron Pharmaceuticals in Q1 2025, an estimated $59.2M increase.
  • Armistice Capital's biggest Q1 2025 reduction was Vertex Pharmaceuticals, cutting an estimated $81.1M.
  • Armistice Capital fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $79.9M.
  • Armistice Capital's ten largest holdings make up 57% of its $6.67B portfolio in Q1 2025.
  • Armistice Capital opened 64 new positions and closed 70 in Q1 2025.
  • Armistice Capital's portfolio value fell 9% quarter-over-quarter to $6.67B.

Based on Armistice Capital's 13F filing for Q1 2025, filed 15 May 2025.